Go Pro

V2X (VVX) Competitors

V2X logo
$75.08 +0.10 (+0.13%)
Closing price 07/10/2026 03:59 PM Eastern
Extended Trading
$75.00 -0.08 (-0.11%)
As of 07/10/2026 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VVX vs. APLD, HQY, STN, QBTS, and Z

Should you buy V2X stock or one of its competitors? MarketBeat compares V2X with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with V2X include Applied Digital (APLD), HealthEquity (HQY), Stantec (STN), D-Wave Quantum (QBTS), and Zillow Group (Z). These companies are all part of the "business services" industry.

How does V2X compare to Applied Digital?

V2X (NYSE:VVX) and Applied Digital (NASDAQ:APLD) are both mid-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

V2X has a net margin of 1.88% compared to Applied Digital's net margin of -52.84%. V2X's return on equity of 16.94% beat Applied Digital's return on equity.

Company Net Margins Return on Equity Return on Assets
V2X1.88% 16.94% 5.74%
Applied Digital -52.84%-15.91%-4.62%

V2X currently has a consensus price target of $80.90, suggesting a potential upside of 7.74%. Applied Digital has a consensus price target of $70.56, suggesting a potential upside of 126.50%. Given Applied Digital's stronger consensus rating and higher probable upside, analysts plainly believe Applied Digital is more favorable than V2X.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
V2X
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46
Applied Digital
2 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
3 Strong Buy rating(s)
2.94

95.2% of V2X shares are owned by institutional investors. Comparatively, 65.7% of Applied Digital shares are owned by institutional investors. 1.0% of V2X shares are owned by company insiders. Comparatively, 9.5% of Applied Digital shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Applied Digital had 18 more articles in the media than V2X. MarketBeat recorded 21 mentions for Applied Digital and 3 mentions for V2X. V2X's average media sentiment score of 0.67 beat Applied Digital's score of 0.53 indicating that V2X is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
V2X
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Applied Digital
7 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
5 Negative mention(s)
0 Very Negative mention(s)
Positive

V2X has higher revenue and earnings than Applied Digital. Applied Digital is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
V2X$4.48B0.52$77.88M$2.7926.91
Applied Digital$319.26M27.88-$231.07M-$0.74N/A

V2X has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, Applied Digital has a beta of 5.67, meaning that its stock price is 467% more volatile than the broader market.

Summary

V2X beats Applied Digital on 9 of the 17 factors compared between the two stocks.

How does V2X compare to HealthEquity?

V2X (NYSE:VVX) and HealthEquity (NASDAQ:HQY) are both mid-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

HealthEquity has lower revenue, but higher earnings than V2X. V2X is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
V2X$4.48B0.52$77.88M$2.7926.91
HealthEquity$1.31B6.01$215.20M$2.6735.36

95.2% of V2X shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 1.0% of V2X shares are owned by company insiders. Comparatively, 1.6% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

V2X has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market.

HealthEquity has a net margin of 17.25% compared to V2X's net margin of 1.88%. V2X's return on equity of 16.94% beat HealthEquity's return on equity.

Company Net Margins Return on Equity Return on Assets
V2X1.88% 16.94% 5.74%
HealthEquity 17.25%14.75%9.22%

In the previous week, HealthEquity had 4 more articles in the media than V2X. MarketBeat recorded 7 mentions for HealthEquity and 3 mentions for V2X. HealthEquity's average media sentiment score of 0.88 beat V2X's score of 0.67 indicating that HealthEquity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
V2X
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HealthEquity
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

V2X currently has a consensus price target of $80.90, suggesting a potential upside of 7.74%. HealthEquity has a consensus price target of $110.57, suggesting a potential upside of 17.13%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than V2X.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
V2X
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.77

Summary

HealthEquity beats V2X on 12 of the 17 factors compared between the two stocks.

How does V2X compare to Stantec?

Stantec (NYSE:STN) and V2X (NYSE:VVX) are both mid-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

Stantec has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, V2X has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

In the previous week, V2X had 1 more articles in the media than Stantec. MarketBeat recorded 3 mentions for V2X and 2 mentions for Stantec. Stantec's average media sentiment score of 0.81 beat V2X's score of 0.67 indicating that Stantec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stantec
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
V2X
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stantec has a net margin of 5.92% compared to V2X's net margin of 1.88%. Stantec's return on equity of 19.37% beat V2X's return on equity.

Company Net Margins Return on Equity Return on Assets
Stantec5.92% 19.37% 8.03%
V2X 1.88%16.94%5.74%

63.9% of Stantec shares are held by institutional investors. Comparatively, 95.2% of V2X shares are held by institutional investors. 0.5% of Stantec shares are held by insiders. Comparatively, 1.0% of V2X shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Stantec has higher revenue and earnings than V2X. Stantec is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stantec$5.83B1.35$343.11M$3.1222.19
V2X$4.48B0.52$77.88M$2.7926.91

Stantec presently has a consensus price target of $175.00, suggesting a potential upside of 152.82%. V2X has a consensus price target of $80.90, suggesting a potential upside of 7.74%. Given Stantec's stronger consensus rating and higher possible upside, research analysts plainly believe Stantec is more favorable than V2X.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stantec
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
V2X
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46

Summary

Stantec beats V2X on 11 of the 16 factors compared between the two stocks.

How does V2X compare to D-Wave Quantum?

V2X (NYSE:VVX) and D-Wave Quantum (NYSE:QBTS) are both mid-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

V2X has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, D-Wave Quantum has a beta of 2.11, meaning that its stock price is 111% more volatile than the broader market.

In the previous week, D-Wave Quantum had 20 more articles in the media than V2X. MarketBeat recorded 23 mentions for D-Wave Quantum and 3 mentions for V2X. D-Wave Quantum's average media sentiment score of 0.68 beat V2X's score of 0.67 indicating that D-Wave Quantum is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
V2X
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
D-Wave Quantum
9 Very Positive mention(s)
7 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

V2X has a net margin of 1.88% compared to D-Wave Quantum's net margin of -2,957.23%. V2X's return on equity of 16.94% beat D-Wave Quantum's return on equity.

Company Net Margins Return on Equity Return on Assets
V2X1.88% 16.94% 5.74%
D-Wave Quantum -2,957.23%-44.06%-38.48%

V2X has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
V2X$4.48B0.52$77.88M$2.7926.91
D-Wave Quantum$24.59M302.05-$355.06M-$1.13N/A

V2X currently has a consensus price target of $80.90, suggesting a potential upside of 7.74%. D-Wave Quantum has a consensus price target of $36.80, suggesting a potential upside of 83.28%. Given D-Wave Quantum's stronger consensus rating and higher possible upside, analysts clearly believe D-Wave Quantum is more favorable than V2X.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
V2X
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46
D-Wave Quantum
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.76

95.2% of V2X shares are held by institutional investors. Comparatively, 42.5% of D-Wave Quantum shares are held by institutional investors. 1.0% of V2X shares are held by insiders. Comparatively, 1.3% of D-Wave Quantum shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

V2X beats D-Wave Quantum on 9 of the 17 factors compared between the two stocks.

How does V2X compare to Zillow Group?

V2X (NYSE:VVX) and Zillow Group (NASDAQ:Z) are both mid-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk and dividends.

V2X has higher revenue and earnings than Zillow Group. V2X is trading at a lower price-to-earnings ratio than Zillow Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
V2X$4.48B0.52$77.88M$2.7926.91
Zillow Group$2.58B2.85$23M$0.25128.76

V2X presently has a consensus price target of $80.90, suggesting a potential upside of 7.74%. Zillow Group has a consensus price target of $76.00, suggesting a potential upside of 136.10%. Given Zillow Group's stronger consensus rating and higher probable upside, analysts clearly believe Zillow Group is more favorable than V2X.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
V2X
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46
Zillow Group
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
3 Strong Buy rating(s)
2.67

95.2% of V2X shares are owned by institutional investors. Comparatively, 71.0% of Zillow Group shares are owned by institutional investors. 1.0% of V2X shares are owned by insiders. Comparatively, 23.8% of Zillow Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Zillow Group had 28 more articles in the media than V2X. MarketBeat recorded 31 mentions for Zillow Group and 3 mentions for V2X. V2X's average media sentiment score of 0.67 beat Zillow Group's score of 0.23 indicating that V2X is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
V2X
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Zillow Group
4 Very Positive mention(s)
2 Positive mention(s)
22 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Zillow Group has a net margin of 2.27% compared to V2X's net margin of 1.88%. V2X's return on equity of 16.94% beat Zillow Group's return on equity.

Company Net Margins Return on Equity Return on Assets
V2X1.88% 16.94% 5.74%
Zillow Group 2.27%1.41%1.22%

V2X has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market. Comparatively, Zillow Group has a beta of 1.98, indicating that its stock price is 98% more volatile than the broader market.

Summary

Zillow Group beats V2X on 9 of the 16 factors compared between the two stocks.

Get V2X News Delivered to You Automatically

Sign up to receive the latest news and ratings for VVX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VVX vs. The Competition

MetricV2XTechnology Services IndustryBusiness SectorNYSE Exchange
Market Cap$2.35B$4.09B$6.91B$23.47B
Dividend YieldN/A2.21%3.13%4.02%
P/E Ratio26.9137.3329.2731.38
Price / Sales0.5245.84347.1186.06
Price / Cash8.2836.8823.2118.65
Price / Book2.184.315.764.77
Net Income$77.88M$31.76M$204.80M$1.06B
7 Day Performance-2.34%0.33%-0.63%-0.39%
1 Month Performance-17.47%-5.36%-1.36%0.05%
1 Year Performance54.69%6.34%16.36%17.05%

V2X Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VVX
V2X
3.8344 of 5 stars
$75.09
+0.1%
$80.90
+7.7%
+54.7%$2.35B$4.48B26.9116,200
APLD
Applied Digital
3.5432 of 5 stars
$30.87
-7.8%
$70.56
+128.5%
+239.3%$8.83B$144.19MN/A121
HQY
HealthEquity
3.9277 of 5 stars
$97.51
+1.0%
$110.57
+13.4%
-0.1%$8.15B$1.31B36.522,814
STN
Stantec
4.7599 of 5 stars
$68.85
-2.6%
$175.00
+154.2%
-37.3%$7.81B$5.83B22.1034,000
QBTS
D-Wave Quantum
3.4149 of 5 stars
$21.08
-6.5%
$36.80
+74.5%
+35.7%$7.77B$24.59MN/A3

Related Companies and Tools


This page (NYSE:VVX) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners